Latest News and Press Releases
Want to stay updated on the latest news?
-
Did you buy GEMI Class A common stock and/or securities between September 12, 2025, and February 17, 2026? Affected GEMI Investor Summary Who: Gemini Space Station, Inc. (NASDAQ: GEMI)What:...
-
WHITE PLAINS, N.Y., April 20, 2026 (GLOBE NEWSWIRE) -- Federal jury in Charlotte, North Carolina has delivered a sharply divided verdict in a closely watched bellwether trial against Uber...
-
Robbins LLP is Investigating Allegations that Pinterest, Inc. (PINS) Misled Investors Regarding its Revenues from Advertising
-
Robbins LLP is Investigating Allegations that Babcock & Wilcox Enterprises, Inc. (BW) Misled Investors Regarding its Business Prospects
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Elauwit...
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options If you purchased or...
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Sezzle (SEZL) To Contact Him Directly To Discuss Their Options If you purchased or...
-
Robbins LLP is Investigating Allegations that Aldeyra Therapeutics, Inc. (ALDX) Misled Investors Regarding its Lead Drug Candidate
-
Robbins LLP is Investigating Allegations that Gossamer Bio, Inc. (GOSS) Misled Investors Regarding the Viability of its PROSERA Study
-
Robbins LLP is Investigating Allegations that ImuunityBio, Inc. (IBRX) Misled Investors Regarding its Lead Product Candidate